TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Bio-Nord AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,578
|
1,481
|
1,273 |
| Financial expenses |
60
|
104
|
26 |
| Earnings before taxes |
-30
|
89
|
7 |
| EBITDA |
30
|
193
|
33 |
| Total assets |
2,069
|
983
|
1,976 |
| Current assets |
2,069
|
983
|
1,976 |
| Current liabilities |
1,968
|
846
|
1,884 |
| Equity capital |
70
|
109
|
64 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
3.4%
|
11.1%
|
3.2% |
| Turnover per employee |
526
|
494
|
424 |
| Profit as a percentage of turnover |
-1.9%
|
6.0%
|
0.5% |
| Return on assets (ROA) |
1.4%
|
19.6%
|
1.7% |
| Current ratio |
105.1%
|
116.2%
|
104.9% |
| Return on equity (ROE) |
-42.9%
|
81.7%
|
10.9% |
| Change turnover |
97
|
208
|
181 |
| Change turnover % |
7%
|
16%
|
17% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.